AFT’s maxigesic hits no.1 in Aus painkiller market

Company News

by Anna Napoli

AFT Pharmaceuticals (ASX:AFP) has announced its codeine-free painkiller Maxigesic is now the largest selling paracetamol-ibprofen combination painkiller in Australian pharmacies.

The rise in sales comes off the back of the Therapeutic Goods Administration's (TGA) decision to make codeine-based painkillers prescription-only.

Weekly sales data from IRi Australia for February shows Maxigesic is now ahead of all other brands in it's category sold at Australian pharmacies.

The company says sales of Maxigesic have roughly doubled since the beginning of the year.

Shares in AFT (ASX:AFP) Last traded at $2.24 on February 21 2018.